# A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients

> **NCT01468493** · — · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 90 (estimated)

## Conditions studied

- FSGS

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01468493
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2017-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468493, "A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01468493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*